Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PCRFY Stock Summary
In the News
PCRFY Financial details
Company Rating
Neutral
Market Cap
21.85B
Income
501.81B
Revenue
8454.73B
Book val./share
1790.86
Cash/share
531.59
Dividend
0.09
Dividend %
0.92%
Employees
230.03K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
7.4
Forward P/E
-
PEG
0.77
P/S
0.39
P/B
0.77
P/C
0.02
P/FCF
15.58
Quick Ratio
0.89
Current Ratio
1.42
Debt / Equity
0.38
LT Debt / Equity
0.32
-
-
EPS (TTM)
214.99
EPS next Y
-
EPS next Q
-
EPS this Y
3.97%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.36%
Revenue last 5Y
0.92%
Revenue Q/Q
4.36%
EPS Q/Q
26.69%
-
-
-
-
SMA20
0.21%
SMA50
-1.85%
SMA100
2.69%
Inst Own
0.49%
Inst Trans
1.05%
ROA
5%
ROE
12%
ROC
0.05%
Gross Margin
28%
Oper. Margin
4%
Profit Margin
5%
Payout
16%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.59-12.7467
52W High
-22%
52W Low
+17%
RSI
45.43
Rel Volume
0.05
Avg Volume
253.18K
Volume
13.53K
Perf Week
-3.01%
Perf Month
-0.32%
Perf Quarter
-
Perf Half Y
-11.95%
-
-
-
-
Beta
1.005
-
-
Volatility
0.12%, 0.15%
Prev Close
-1.27%
Price
9.36
Change
-0.43%
PCRFY Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.43K | 3.21K | 2.87K | 3.17K | 3.59K | |
Net income per share | 121.83 | 96.76 | 70.75 | 109.42 | 113.76 | |
Operating cash flow per share | 87.33 | 184.47 | 216.04 | 108.26 | 223.12 | |
Free cash flow per share | -83.69 | 36.45 | 88.98 | -19.35 | 64.64 | |
Cash per share | 387.4 | 499.41 | 747 | 607.02 | 423.82 | |
Book value per share | 820.42 | 856.7 | 1.11K | 1.36K | 1.55K | |
Tangible book value per share | 585.27 | 658.17 | 928.56 | 714.43 | 854.23 | |
Share holders equity per share | 820.42 | 856.7 | 1.11K | 1.36K | 1.55K | |
Interest debt per share | 437.05 | 645.36 | 628.36 | 821.3 | 633.36 | |
Market cap | 2290.49B | 1874.71B | 3364.59B | 2773.76B | 2763.76B | |
Enterprise value | 2516.95B | 2329.52B | 3218.79B | 3465.17B | 3401.37B | |
P/E ratio | 8.06 | 8.31 | 20.38 | 10.86 | 10.41 | |
Price to sales ratio | 0.29 | 0.25 | 0.5 | 0.38 | 0.33 | |
POCF ratio | 11.25 | 4.36 | 6.68 | 10.98 | 5.31 | |
PFCF ratio | -11.73 | 22.05 | 16.21 | -61.44 | 18.32 | |
P/B Ratio | 1.2 | 0.94 | 1.3 | 0.88 | 0.76 | |
PTB ratio | 1.2 | 0.94 | 1.3 | 0.88 | 0.76 | |
EV to sales | 0.31 | 0.31 | 0.48 | 0.47 | 0.41 | |
Enterprise value over EBITDA | 3.43 | 3.34 | 5.39 | 4.82 | 4.73 | |
EV to operating cash flow | 12.36 | 5.41 | 6.39 | 13.72 | 6.53 | |
EV to free cash flow | -12.9 | 27.4 | 15.5 | -76.75 | 22.55 | |
Earnings yield | 0.12 | 0.12 | 0.05 | 0.09 | 0.1 | |
Free cash flow yield | -0.09 | 0.05 | 0.06 | -0.02 | 0.05 | |
Debt to equity | 0.52 | 0.74 | 0.56 | 0.6 | 0.4 | |
Debt to assets | 0.17 | 0.24 | 0.21 | 0.24 | 0.18 | |
Net debt to EBITDA | 0.31 | 0.65 | -0.24 | 0.96 | 0.89 | |
Current ratio | 1.1 | 1.31 | 1.4 | 1.32 | 1.32 | |
Interest coverage | 19.93 | 8.62 | 13.88 | 18.56 | 13.65 | |
Income quality | 0.67 | 1.79 | 2.74 | 0.95 | 1.86 | |
Dividend Yield | 0.04 | 0.04 | 0.02 | 0.02 | 0.03 | |
Payout ratio | 0.29 | 0.31 | 0.35 | 0.23 | 0.26 | |
Sales general and administrative to revenue | 0.24 | 0.25 | 0.25 | 0.23 | 0.23 | |
Research and developement to revenue | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | |
Intangibles to total assets | 0.12 | 0.1 | 0.09 | 0.21 | 0.22 | |
Capex to operating cash flow | -1.96 | -0.8 | -0.59 | -1.18 | -0.71 | |
Capex to revenue | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | |
Capex to depreciation | -1.35 | -0.93 | -0.93 | -0.88 | -0.97 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.5K | 1.37K | 1.33K | 1.83K | 1.99K | |
ROIC | 0.1 | 0.06 | 0.04 | 0.05 | 0.05 | |
Return on tangible assets | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 | |
Graham Net | -696.53 | -649.5 | -436.14 | -728.55 | -704.42 | |
Working capital | 284.64B | 819.73B | 1118.42B | 965.73B | 929.47B | |
Tangible asset value | 1365.06B | 1535.26B | 2166.46B | 1667.14B | 1993.72B | |
Net current asset value | -655.22B | -626.82B | -155.82B | -645.22B | -466.68B | |
Invested capital | 0.52 | 0.74 | 0.56 | 0.6 | 0.4 | |
Average receivables | 1114.8B | 1252.59B | 1258.52B | 1263.56B | 1323.61B | |
Average payables | 1148.83B | 1060.43B | 1007.66B | 1104.6B | 1160.24B | |
Average inventory | 1002.52B | 904.98B | 813.04B | 982.62B | 1210.71B | |
Days sales outstanding | 54.3 | 64.06 | 65.52 | 65.44 | 57.61 | |
Days payables outstanding | 73.25 | 66.29 | 80.79 | 80.03 | 69.03 | |
Days of inventory on hand | 64.68 | 54.24 | 64.33 | 77.91 | 76.89 | |
Receivables turnover | 6.72 | 5.7 | 5.57 | 5.58 | 6.34 | |
Payables turnover | 4.98 | 5.51 | 4.52 | 4.56 | 5.29 | |
Inventory turnover | 5.64 | 6.73 | 5.67 | 4.69 | 4.75 | |
ROE | 0.15 | 0.11 | 0.06 | 0.08 | 0.07 | |
Capex per share | -171.01 | -148.03 | -127.05 | -127.61 | -158.48 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 925.71 | 923.01 | 869.59 | 895.29 | 934.32 | |
Net income per share | 23.79 | 43.97 | 86.08 | 37.47 | 47.47 | |
Operating cash flow per share | 44.75 | 88.69 | 97.09 | 70.75 | 88.5 | |
Free cash flow per share | 4.76 | 37.1 | 39.92 | 9.09 | 17.75 | |
Cash per share | 414.99 | 423.79 | 467.15 | 585.27 | 531.59 | |
Book value per share | 1.48K | 1.55K | 1.76K | 1.84K | 1.79K | |
Tangible book value per share | 792.74 | 854.17 | 1.02K | 1.92K | 1.87K | |
Share holders equity per share | 1.48K | 1.55K | 1.76K | 1.84K | 1.79K | |
Interest debt per share | 654.88 | 626.47 | 640.53 | 726.82 | 685.86 | |
Market cap | 2533.16B | 2763.96B | 4136.26B | 3959.48B | 3237.46B | |
Enterprise value | 3235.7B | 3401.56B | 4716.37B | 4484.35B | 3792.77B | |
P/E ratio | 11.4 | 6.73 | 5.15 | 11.32 | 7.3 | |
Price to sales ratio | 1.17 | 1.28 | 2.04 | 1.89 | 1.48 | |
POCF ratio | 24.25 | 13.35 | 18.25 | 23.98 | 15.67 | |
PFCF ratio | 228.11 | 31.92 | 44.39 | 186.64 | 78.12 | |
P/B Ratio | 0.73 | 0.76 | 1.01 | 0.92 | 0.77 | |
PTB ratio | 0.73 | 0.76 | 1.01 | 0.92 | 0.77 | |
EV to sales | 1.5 | 1.58 | 2.32 | 2.15 | 1.74 | |
Enterprise value over EBITDA | 16.95 | 20.79 | 22.44 | 20.28 | 15.05 | |
EV to operating cash flow | 30.98 | 16.43 | 20.81 | 27.16 | 18.36 | |
EV to free cash flow | 291.37 | 39.28 | 50.62 | 211.39 | 91.52 | |
Earnings yield | 0.02 | 0.04 | 0.05 | 0.02 | 0.03 | |
Free cash flow yield | 0 | 0.03 | 0.02 | 0.01 | 0.01 | |
Debt to equity | 0.44 | 0.4 | 0.36 | 0.39 | 0.38 | |
Debt to assets | 0.19 | 0.18 | 0.17 | 0.19 | 0.18 | |
Net debt to EBITDA | 3.68 | 3.9 | 2.76 | 2.37 | 2.2 | |
Current ratio | 1.31 | 1.32 | 1.35 | 1.42 | 1.39 | |
Interest coverage | 14.46 | 10.58 | 18.1 | 15.41 | 17.47 | |
Income quality | 1.85 | 1.92 | 1.1 | 1.81 | 1.78 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0 | 0.01 | |
Payout ratio | 0.63 | 0 | 0.17 | 0 | 0.37 | |
Sales general and administrative to revenue | 0.22 | 0.24 | 0.24 | 0.24 | 0.25 | |
Research and developement to revenue | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | |
Intangibles to total assets | 0.22 | 0.22 | 0.22 | 0.21 | 0.21 | |
Capex to operating cash flow | -0.89 | -0.58 | -0.59 | -0.87 | -0.8 | |
Capex to revenue | -0.04 | -0.06 | -0.07 | -0.07 | -0.08 | |
Capex to depreciation | -0.97 | -1.24 | -1.38 | -1.45 | -1.65 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 890.76 | 1.24K | 1.85K | 1.25K | 1.38K | |
ROIC | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | |
Return on tangible assets | 0.01 | 0.02 | 0.03 | 0.01 | 0.02 | |
Graham Net | -743.78 | -704.37 | -722.17 | -687.03 | -734.31 | |
Working capital | 924.04B | 929.47B | 1050.37B | 1276.87B | 1129.18B | |
Tangible asset value | 1850.23B | 1993.72B | 2370.91B | 2522.78B | 2473.76B | |
Net current asset value | -490B | -466.68B | -426.84B | -346.1B | -503.44B | |
Invested capital | 0.44 | 0.4 | 0.36 | 0.39 | 0.38 | |
Average receivables | 1336.85B | 1306.5B | 1315.39B | 1319.8B | 1297.81B | |
Average payables | 1282.56B | 1210.36B | 1189.26B | 1214.64B | 1191.87B | |
Average inventory | 1420.83B | 1347.44B | 1333.81B | 1367.13B | 1326.96B | |
Days sales outstanding | 53.75 | 55.25 | 58.01 | 57.34 | 52.17 | |
Days payables outstanding | 71.46 | 67.16 | 76.27 | 73.29 | 69.69 | |
Days of inventory on hand | 79.51 | 74.82 | 86.09 | 82.26 | 76.95 | |
Receivables turnover | 1.67 | 1.63 | 1.55 | 1.57 | 1.73 | |
Payables turnover | 1.26 | 1.34 | 1.18 | 1.23 | 1.29 | |
Inventory turnover | 1.13 | 1.2 | 1.05 | 1.09 | 1.17 | |
ROE | 0.02 | 0.03 | 0.05 | 0.02 | 0.03 | |
Capex per share | -39.99 | -51.59 | -57.17 | -61.66 | -70.75 |
PCRFY Frequently Asked Questions
What is Panasonic Corporation stock symbol ?
Panasonic Corporation is a JP stock and trading under the symbol PCRFY
What is Panasonic Corporation stock quote today ?
Panasonic Corporation stock price is $9.36 today.
Is Panasonic Corporation stock public?
Yes, Panasonic Corporation is a publicly traded company.